Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.
Gene therapies again generated buzz at the 2024 AAO meeting—as they have at recent meetings—but perhaps most exciting were reports of a treatment that could partially restore severe vision loss fro...
Carl Zeiss Meditec featured its Micor 700 at the 2024 meeting of the American Academy of Ophthalmology in Chicago, Illinois, with presentations that included booth talks by select US surgeons who h...
Ophthalmology remains an appealing investment, driven largely by procedural growth. While hundreds of companies are working toward technology enhancements and innovative therapies, ophthalmology pr...
The explosive growth of artificial intelligence has generated both fear and excitement among many in the ophthalmic industry. As technology progresses, so do the conversations at major meetings, wi...
Several sessions at the 2024 American Academy of Ophthalmology meeting highlighted the trend of office-based surgery (OBS) and the option of oral sedation among practitioners. The consensus among t...
William Boyd, MD, deputy director of ophthalmology at the US FDA’s Office of New Drugs, had a quick answer when asked to name the biggest unmet need in ophthalmology. “We need and want more therapi...
The celebrations and excitement that accompanied the launch in 2023 of the first two drugs approved in the US for the treatment geographic atrophy (GA) gave way to a hangover and regrets at the 202...
Recent studies indicate that up to 6 percent of the US population is currently taking a GLP-1 receptor agonist, a class of drugs prescribed to help manage blood glucose levels for diabetes and weig...
Bausch + Lomb’s enVista Envy and J&J Vision’s Odyssey are two new trifocal IOLs that were shown at the 2024 AAO meeting in Chicago. They are expected to help reverse the decline in trifocal IOL sal...
New glaucoma lasers and surgical devices were shown at various venues during the 2024 AAO meeting, including Glaucoma Subspecialty Day and the Eyecelerator meeting. There was also an important upda...
Alcon launched at the 2024 AAO meeting two new retinal surgical devices—Unifeye for air-gas exchange and Unipexy for retinopexy. Each is a one-person, hand-held, single-use gas delivery device. The...
Expanding the donor pool was once again top of mind at the 2024 Cornea and Eye Banking Forum, held Oct. 18 in conjunction with the AAO meeting in Chicago, Illinois. The forum, supported by the Eye ...
The first-ever ASCRS Business of Refractive Cataract Surgery (BRiCS) Summit was a two-day course designed to equip practices with the knowledge, resources, and confidence to boost their adoption of...
Barcelona, Spain, hosted the ESCRS congress for the third time in the 42-year history of the meeting and set a record for the highest attendance to date. Nearly 17 thousand people registered, 60 pe...
The big news at the 24th Euretina congress was something that didn’t happen at the congress. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) embarrassed Apelli...
European regulators’ repeated rejection of Syfovre made one thing very clear to retina specialists at Euretina: “Treatment should have an impact on everyday function,” said Thomas Ach, MD (Germany)...
Experienced retina surgeons among the approximately 8.1 thousand attendees at Euretina in Barcelona, Spain, were underwhelmed by the surgical devices that industry had on display. “There is nothing...
The impact of Europe’s new Medical Device Regulation (MDR) on innovation sparked considerable discussion during the ESCRS iNovation Day. The meeting was held Sept. 6 in Barcelona, Spain, ahead of t...
Patient selection, education, and communication were emphasized throughout the International Society of Presbyopia’s 16th annual conference. The meeting, held Sept. 5 at the Hyatt Regency Hotel in ...
Sustainability was a theme for multiple sessions at this year’s ESCRS congress, including one called “Sustainability Without Borders,” hosted by the ESCRS’ Young Ophthalmologists for Sustainability...
The 2024 Ophthalmology Futures European Forum reviewed the decline in ophthalmic deals in 2024 before offering presenting companies some guidance on how to advance their technology in such an envir...
Dan Reinstein, MD (UK), shared during an overly full symposium at the 2024 ESCRS congress his experience using Zeiss’ SMILE lenticule extraction procedure to treat hyperopic patients. Zeiss is the ...
Farhad Hafezi, MD, PhD, FARVO (Switzerland), discussed at the 2024 ESCRS congress the goals of the second global consensus on keratoconus, being drafted in 2024. This consensus encompasses feedback...
The 2024 ESCRS congress celebrated the 75th anniversary of Sir Harold Ridley, MD, implanting the first intraocular lens by telling his story and describing the developments that have occurred since...
New and recently launched IOLs took the spotlight in presentations and on the exhibit floor at the 2024 ESCRS congress. These lenses included the Rayner RayOne Galaxy trifocal, the BVI Serenity Mon...
Rick Lewis, MD, chief medical officer at ViaLase, provided an update at the 2024 ESCRS congress on the ViaLuxe glaucoma laser, including the system’s most recent clinical trial results. The ViaLuxe...
Bausch + Lomb showcased its CE marked Octavius at the 2024 ESCRS Congress. Octavius is a new treatment mode on the Teneo excimer laser that uses data from multiple diagnostic platforms to provide a...
Nearly 3 thousand attendees from 127 countries participated in the 2024 World Ophthalmology Congress (WOC), the biennial meeting of the International Council of Ophthalmology (ICO). Over 500 attend...
Market Scope will be exhibiting at the 2024 AAO meeting, set for Oct. 18-21 at McCormick Place in Chicago. We will be located at Booth 4903. Contact us to set up a time to discuss any custom resear...
Myopia—especially progression of myopia—is getting increased attention from industry and physicians, as evidenced by the sheer number of studies published on the topic. Additionally, data showing h...
Eleven sessions, 52 presentations, and numerous posters at the 2024 World Ophthalmology Congress were dedicated to ocular traumas and emergencies. Conflict zones present ophthalmologists and manufa...
Ron Adelman, MD, MPH, MBA (US), shared findings at the 2024 World Ophthalmology Congress from a study that evaluated the level of burnout among ophthalmologists in the Philippines. Results showed t...
Impressive new science and challenging business conditions topped the discussions at the American Society of Retina Specialists’ 2024 annual meeting. The conference took place July 17-20 in Stockho...
Market Scope will be exhibiting at the 2024 ESCRS congress, which is Sept. 6-10 in Barcelona, Spain. We will be located at Stand 6.D12. Contact us to set up a time to discuss any custom research ne...
The 2024 Octane Ophthalmology Tech Forum changed up its program from previous years, putting more focus on practice management and moving to a new location: the VEA Newport Beach, in Newport Beach,...
Attendees at the 2024 Eye Banking Association of America (EBAA) meeting celebrated many achievements and milestones across the eye banking profession and transplant community in general, as 2023 ma...
A sparsely attended Champalimaud Vision Award Lecture at the 2024 ARVO meeting highlighted the work of St. John of Jerusalem Eye Hospital in Gaza, Jerusalem, and the West Bank. Leonor Beleza, presi...
The 2024 meeting of the Association for Research in Vision and Ophthalmology set a record as the largest ARVO meeting ever. The 11,631 registered attendees passed the old record of 10,224 set in Va...
Many companies participate in ARVO’s annual meeting to catch the attention of external researchers and propel their research program or clinical trials forward. Two such companies in 2024 were John...
Artificial intelligence was a prominent topic at the 2024 ARVO meeting. Discussions ranged from using AI in published ophthalmic research to employing it in early detection and monitoring of eye di...
The Weisenfeld and Cogan awards and lectures at the 2024 ARVO meeting put a spotlight on inflammation. Martine Jager, MD, PhD (Netherlands), received the Weisenfeld Award in recognition of her pion...
Nearly 7,800 delegates attended the 2024 congress of the Asia-Pacific Academy of Ophthalmology in southern Bali from Feb. 22-25. The 253 sessions and 120 exhibits spread across four floors in two n...
Market Scope will be located at Booth 3080 at the 2024 ASCRS meeting in Boston, set for April 5-8. Contact us to set up a time to discuss your custom research needs and to learn about our new repor...
Innovative diagnostics for glaucoma screening, staging, and management were a highlight of the Glaucoma 360 New Horizons Forum, with several physicians showcasing new approaches to visual field tes...
Germany’s VSY Biotechnology launched its Enova Maestro trifocal toric preloaded intraocular lens (IOL) at the European Society of Cataract and Refractive Surgeons (ESCRS) Winter Meeting, held Feb. ...
Sight Sciences announced Feb. 14 that it would launch the Ergo-Series of its Omni system for canaloplasty in Europe at the European Society of Cataract and Refractive Surgeons (ESCRS) Winter Meetin...
Ophthalmologist (MD) and optometrist (OD) attendees of the 2024 Glaucoma 360 (G360) meeting demonstrated a record interest in participating in the Ninth Annual G360 Survey powered by Market Scope. ...
Two of ophthalmology’s leading innovators headlined the New Horizons Forum at the Glaucoma 360 meeting. Sean Ianchulev, MD—arguably the most prolific ophthalmic product inventor in the US—led off t...
Attendees of the G360 New Horizons Forum received a detailed breakdown of the battle that the ophthalmic industry collectively waged throughout 2023 to stop proposed limits to Medicare coverage for...
US glaucoma specialists have over 20 surgical options to treat their patients, but even more devices are available or in the pipeline outside the US, and their developers could seek FDA approval. M...
The use of complement inhibitors to slow the progression of geographic atrophy (GA) is shaping up as the fulcrum for changing how ophthalmologists deliver and get compensated for retina care. Two c...
The advantages and disadvantages of immediate sequential bilateral cataract surgery (ISBCS) took center stage during a 2023 AAO Refractive Day session that tasked Rupert Menapace, MD (Austria), wit...
Surgeons attending the Refractive Subspecialty Day at the 2023 AAO meeting in San Francisco debated the ideal treatment options for patients with moderate to high myopia. Practices shared widely di...
The 2023 Euretina congress presented an array of information and technologies that could make European retina specialists better prepared for the arrival of treatments for geographic atrophy than w...
The Visudyne shortage is into its third year in Europe after emerging in May 2020 due a reduction in manufacturing capacity, according to the European Medicines Agency. The shortage made the questi...
The 2023 meeting of the American Academy of Ophthalmology drew 15,661 in-person attendees Nov. 3-6 to Moscone Center in San Francisco, according to preliminary numbers released by the AAO. Another ...
Dry Eye: New products kept generating buzz around dry eye. Bausch + Lomb leaned into the promotion of Miebo, the new, first-in-class drug therapy that directly targets tear evaporation. Diagnostic ...
Eyecelerator awarded a total of $45 thousand in prize money to winning pitch challengers at its fall meeting, after emerging companies got a chance to work with accomplished industry veterans to re...
RxSight—already the fastest growing IOL company in the US—is conducting a controlled launch of an additional version of the Light Adjustable Lens (LAL), referred to as the LAL+. Stephen Slade, MD, ...
Trifocal IOLs went head-to-head with extended depth of focus lenses during the 2023 AAO Refractive Day program as Damien Gatinel, MD, PhD (France), advocated for trifocal models and Douglas Koch, M...
The University of California, San Francisco (UCSF), held its Ophthalmology Showcase on Nov. 3 to highlight both the school’s history of ophthalmic innovation and its role in future advancements. Th...
Sustainability sessions at the 2023 AAO meeting echoed the sentiment of the ESCRS and other ophthalmic meetings throughout the year. US ophthalmologists discussed how practices can implement protoc...
Notable diagnostic innovations showcased at the 2023 meeting of the American Academy of Ophthalmology were Topcon’s Tempo perimeter and Heidelberg Engineering’s Anterion anterior OCT platform. Also...
European cataract surgeons now have access to nearly 100 presbyopia-correcting IOLs, after five new lenses made their debut at the 2023 congress of the European Society of Cataract and Refractive S...
Ophthalmologists told companies at the second annual ESCRS iNovation Day that they were looking for integrated devices and easy access to data at an affordable price. The forum, held Sept. 8 in Vie...
Kuldev Singh, MD (US), co-founder of Europe’s annual Ophthalmology Futures Forums (OFF), told Market Scope in October that he takes pride in the group’s record of giving “people with new ideas who ...
We will have multiple representatives attending the AAO meeting from Nov. 3-6 at the Moscone Center in San Francisco. To schedule a time to meet with us, please email Matthew Douty at matt@market-s...
Nearly 16 thousand people attended the 2023 congress of the European Society of Cataract and Refractive Surgeons, according to Oliver Findl, MD (Austria), president of the ESCRS, who announced the ...
Minimally Invasive Glaucoma Surgery (MIGS): The ESCRS highlighted the growing importance of MIGS this year by holding the meeting’s first MIGS master class. Several speakers in other sessions extol...
Johnson & Johnson Vision announced the launch of the Elita platform’s lenticule extraction (LE) procedure during the 2023 congress of the European Society of Cataract and Refractive Surgeons. The s...
Cornea Subspecialty Day has become the most popular pre-meeting event at the annual congress of the European Society of Cataract and Refractive Surgeons, with 629 attendees this year. Cornea specia...
Ukrainian ophthalmologists are struggling to restore sight to soldiers and confronting complex surgical cases, even as the Russian offensive continues in their country. A large contingent of 825 Uk...
The International Society of Presbyopia highlighted new treatment approaches that come with some interesting names. The conference was held Sept. 7 at the Vienna Marriott Hotel in Vienna, Austria. ...
Eye surgeons swapped their scrubs for boxing robes at the 2023 congress of the European Society of Cataract and Refractive Surgeons, as they took part in the society’s high-profile battle against s...
Pegcetacoplan, the first approved therapy for the treatment of geographic atrophy (GA), was the top story at the American Society of Retina Specialists’ (ASRS) annual meeting, held this year in Sea...
Photoreceptor health and ellipsoid zone integrity: Ursula Schmidt-Erfurt pioneered the process of using computers to help analyze OCT images to interpret the health of photoreceptors. The US FDA ha...
Reginald Sanders, MD, opened the Saturday sessions of the 2023 meeting of the American Society of Retina Specialists (ASRS) with a presentation on the association’s conflict of interest policy. It ...
Firas Rahhal, MD, moderator and co-chair of the 2023 OIS Retina meeting, said he didn’t want company pitches to focus only on their science—and most of them didn’t. “The point of pitches at OIS (fo...
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.